Nektar Therapeutics (NKTR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

3.7500

-0.0500

(-1.32%)

At close: 04:00PM EDT

3.7500

0.00

(0.00%)

After hours:

04:24PM EDT

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

PR Newswire
Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer
Nektar Therapeutics (Nasdaq: NKTR) today announced the promotion of Jillian B. Thomsen to Senior Vice President (SVP) & Chief Financial Officer. Ms. Thomsen has served as SVP, Finance & Chief Accounting Officer of Nektar since 2008, and is a key member of our Executive Committee. Gil Labrucherie, the company's current Chief Operating Officer & Chief Financial Officer, will be departing the company to pursue another opportunity at a private biotechnology company.
American City Business Journals
After a record-breaking decade, biotech is discovering what hard times feel like
An investment climate that's suddenly turned chilly may leave promising companies out in the cold.
Simply Wall St.
Is Nektar Therapeutics (NASDAQ:NKTR) In A Good Position To Deliver On Growth Plans?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Advertisement